<div id="gangagen-mission" class="gg-japanese-laurel">
  <div class="centerize ctz-lg px-3 py-5 text-center">
    <h2 class="fw-700 abx-white-text anim-hidden fade-in">Our mission is to discover, design and develop highly specific and safe Protein Antiobiotics for treating bacterial infections.</h2>
  </div>
</div>

<div id="gangagen-overview">

  	<div class="abx-white" style="background:linear-gradient(rgba(0,0,0,0.4),rgba(0,0,0,0.4), url('/wp-content/uploads/2020/09/gangagen-facility-05.jpg');">
        <div class="centerize ctz-lg px-3 py-5">
           <div class="row">
              <div class="">
                  <div class="content-group mb-4 anim-hidden fade-in-left">
                    <h2 class="text-center abx-white-text fw-700">Overview</h2>
                    <p class="text-left abx-white-text" style="font-size:1.4rem; line-height:2;">GangaGen Biotechnologies Private Limited, India (GBPL), is a biologics company specialized in discovering, designing and developing novel therapies for treating serious bacterial infections. GangaGen advanced it’s candidate compound into human clinical trials for the decolonization of Methicillin Resistant <em>Staphylococcus aureus</em> from human nares in 2015.</p>
                  </div>
              </div>
           </div>
        </div>
    </div>
  
    <div class="gg-light">
        <div class="centerize ctz-lg px-3 py-5">
           <div class="row">
                <div class="col-12 col-md-6 py-3 text-center">
                    <div class="content-group mb-4 anim-hidden fade-in-left">
                      <img src="/wp-content/uploads/2020/09/gangagen-beginninigs-e1600361407146.jpg" alt="gangagen-image" />
                    </div>
                </div>
             	<div class="col-12 col-md-6 py-2">
                    <div class="content-group mb-4 anim-hidden fade-in-right">
                      <h2 class="text-center gg-japanese-laurel-text fw-700">GBPL's Beginnings</h2>
                      <p class="text-left" style="font-size:1.4rem; line-height:2;">GBPL was founded and registered in India in 2000 by Prof J. Ramachandran and became a subsidiary of GangaGen Inc., a Delaware company in the US in 2001. The assets of GangaGen Inc. were transferred to Bactoclear Holdings in 2019.</p>
                    </div>
                </div>
            </div>
        </div>
  	</div>
  
    <div class="abx-white">
        <div class="centerize ctz-lg px-3 py-5">
           <div class="row">
                <div class="col-12 py-2 text-center">
                    <div class="content-group mb-4 anim-hidden fade-in-up">
                      <h2 class="text-center gg-japanese-laurel-text fw-700">GBPL Ownership</h2>
                      <p class="text-left" style="font-size:1.4rem; line-height:2;">GBPL is a wholly owned subsidiary of <span class="gg-japanese-laurel-text fw-900">Bactoclear Holdings Pte. Ltd., a Singapore company</span>. The board of Bactoclear Holdings is made up of investors from different parts of the world, committed to make a difference in tackling antimicrobial resistance.</p>
                    </div>
                </div>
            </div>
        </div>
  	</div>
  
  	<div class="gg-japanese-laurel abx-white-text text-center" style="border-bottom:solid 3px var(--gg-light);">
      <div class="centerize ctz-lg px-3 py-5">
      	<h2 class="anim-hidden fade-in-up">GangaGen's Research Focus</h2>
      	<p class="anim-hidden fade-in-up text-left" style="font-size:1.4rem; line-height:2;">GangaGen’s expertise towards designing novel Protein Antibiotics is based on its proprietary technology platforms</p>
      </div>
    </div>
  
</div>